Genetic determinants of heritable venous thrombosis: genotyping methods for factor VLEIDEN A1691G, methylenetetrahydrofolate reductase C677T, prothrombin G20210A mutation, and algorithms for venous thrombosis investigations

This publication has 20 references indexed in Scilit:

• Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
  Published by American Medical Association (AMA) ,1997
• Oral Contraceptives and Thrombotic Disease: Risk of Venous Thromboembolism
  Thrombosis and Haemostasis, 1997
• The inherited basis of venous thrombosis
  Pathology, 1997
• Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations
  Circulation, 1996
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995
• Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
  The Lancet, 1995
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Resistance to Activated Protein C as a Basis for Venous Thrombosis
  New England Journal of Medicine, 1994
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
  The Lancet, 1993
• Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]
  Blood, 1993